Therapy Market Research Reports & Industry Analysis
Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.
Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.
The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.
... titled “Global Allergy Immunotherapy Market (2017-2021 Edition)”, provides an in-depth analysis of the global allergy immunotherapy market by value, by methods of administration, by region, etc. The report provides a regional analysis of the allergy immunotherapy market, including ...
Oct, 2017 70 pages... relatively optimistic growth, the past four years, Testosterone Replacement Therapy market size to maintain the average annual growth rate ... years, Testosterone Replacement Therapy market size will be further expanded, we expect that by 2021 , The market size of the Testosterone Replacement Therapy will reach ...
Oct, 2017 130 pages... releases. The Radiation Injury (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Radiation Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
Oct, 2017 46 pages... releases. The Heavy Metal Poisoning (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Heavy Metal Poisoning and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
Oct, 2017 40 pages... Fibrosis Therapeutics Market & Forecast (2014 – 2024) 2. Global Cystic Fibrosis Therapeutics Market - Major Marketed Products Sales & Forecast (2012 - 2024) 3. Global Cystic Fibrosis Therapeutics Market - Pharmacological Class Sales & Forecast (2015 – 2021) 4. By Geography - Cystic Fibrosis Therapeutics ...
Oct, 2017 121 pages... of relaxation, pain relief, and stress relief - even inducing a meditative state in some cases. Dry salt therapy is believed to provide relief from respiratory ailments including asthma, sinusitis, bronchitis, and COPD. It may also ...
Sep, 2017 23 pages... Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
Sep, 2017 69 pages... identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) development landscape Develop ...
Sep, 2017 63 pages... Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
Sep, 2017 63 pages... . The Pseudomonas aeruginosa Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pseudomonas aeruginosa Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
Sep, 2017 32 pages... . The Marburgvirus Infections (Marburg Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Marburgvirus Infections (Marburg Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
Sep, 2017 78 pages... releases. The Malignant Pleural Effusion (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Malignant Pleural Effusion and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
Sep, 2017 32 pages... . The Influenzavirus B Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenzavirus B Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
Sep, 2017 120 pages... . The Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H5N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
Sep, 2017 151 pages... . The Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H1N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
Sep, 2017 209 pages... releases. The Hepatic - Colorectal Metastasis (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hepatic - Colorectal Metastasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
Sep, 2017 39 pages... . The Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Epstein-Barr Virus (HHV-4) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
Sep, 2017 74 pages... releases. The Ependymoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ependymoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
Sep, 2017 131 pages... releases. The Dupuytren Contracture (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Dupuytren Contracture and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
Sep, 2017 31 pages... . The Influenza A Virus, H3N2 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H3N2 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
Aug, 2017 127 pages... therapy centers as well as its elongated history of proton therapy. USA leads the Pediatric Proton Therapy Market globally USA has the highest pediatric proton therapy market ... and Japan. This report provides the data on USA Pediatric Proton Therapy Market & Patients numbers, in 36 Cancer Types. Out of these ...
Aug, 2017... on geography: Americas APAC EMEA Technavio's report, Global Pruritus Therapeutic Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The ...
Aug, 2017 81 pagesThe Global Radiotherapy Market Analysis & Forecast Report 2017 is a professional and in-depth study on the current state of the Radiotherapy Market. The report analysis the global market of Radiotherapy by main manufactures and geographic ...
Jul, 2017 95 pagesThe Global Continuous Renal Replacement Therapy (CRRT) Market Analysis & Forecast Report 2017 is a professional and in-depth study on the current state of the Continuous Renal Replacement Therapy (CRRT) Market. The report ...
Jul, 2017 95 pages... . The Complex Regional Pain Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Complex Regional Pain Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development ...
Jul, 2017 39 pages... . The Cluster Headache Syndrome (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cluster Headache Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development ...
Jul, 2017 39 pages... Points 1. Global Proton Therapy Actual & Potential Market Analysis (2010 - 2022) 2. Global Proton Therapy Actual & Potential Candidate Analysis (2010 - 2022) 3. Global Proton Therapy Market Share Analysis (2010 - 2022) 4. Global Proton Therapy Candidate Share Analysis (2010 - 2022) 5. Proton Therapy Actual & Potential Market - Regional ...
Jul, 2017 411 pages... for radiotherapy. Key Players are profiled and their strategies are analyzed thoroughly to understand competitive outlook of the global market. KEY MARKET SEGMENTS BY TYPE External Beam Radiation Therapy By Product Compact Advanced Radiotherapy Systems Cyberknife Gamma Knife Tomotherapy Proton Therapy Systems Conventional Radiotherapy ...
Jun, 2017 140 pagesIntravenous (IV) therapy is the process of infusion of liquid substances, such as electrolytes, medicines, nutrition, and blood-based products, directly into the vein as a therapeutic treatment. Intravenous therapy ... STKEHOLDERS The study provides an in-depth analysis of the global intravenous therapy and vein access market, with current trends and future estimations to elucidate ...
Jun, 2017 175 pages... by RNCOS titled, "Global Cystic Fibrosis Therapeutics Market Outlook 2022”, unfolds the market dynamics of the cystic fibrosis therapeutics market. According to this new research report, the market for cystic fibrosis therapeutics was valued at US$ 1.94 Billion ... for largest share in the total cystic fibrosis therapeutics market in 2016. Additionally, the report covers the geographic analysis of the global cystic fibrosis therapeutics market by segmenting into three major ...
Jul, 2017 140 pages... Coupon value of $300. PHYSICAL & OCCUPATIONAL THERAPISTS REVENUES WORLD REPORT DATABASE EDITION The Market for Physical & Occupational Therapists Revenues in each country by Products & Services. The Physical & Occupational Therapists Revenues World Report covers ...
Jul, 2017 839 pagesPHYSICAL & OCCUPATIONAL THERAPISTS PURCHASING WORLD PDF REPORT See descriptive brochure: here The Physical & Occupational Therapists Purchasing World Report gives data on a list of 42 categories of Raw Materials, Semi- ... , by each country, by Year. This Physical & Occupational Therapists Purchasing World Report is a PDF Summary Edition.807 pages. Updated monthly. UPGRADE: A Purchasing World Database Edition of this ...
Jul, 2017 807 pagesGlobal Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse SUMMARY The pain therapeutics market ...
Jun, 2017 147 pages... , global stem cell therapy market is expected to grow at a CAGR of 12.2% from 2017 to 2025. According to therapy mode, the market is divided into autologous stem cell therapy and allogeneic stem cell therapy. According to application, the market is divided ... of stem cell therapy. Restraints: Lack of infrastructure needed for the R&D of stem cell therapy. Ethical issues associated with the embryonic stem cells. MARKET PLAYERS: The top players in the global stem cell therapy market include ...
Mar, 2017... to sports medicine and orthopedic treatments. Global plasma therapy market is expected to grow at a CAGR of 13.5% from 2017 to 2025. Based on type, the global plasma therapy market is segmented as Leucocyte-rich PRP ... of platelet rich plasma for treatment of various diseases. Restraints: High cost of plasma therapy. MARKET PLAYERS: The top players in the global plasma therapy market include Biolife Plasma Services, Biotest ...
Mar, 2017... pipeline guide Usher Syndrome - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Usher Syndrome (Genetic Disorders), complete with analysis by stage of development ...
Jun, 2017 34 pages... pipeline guide Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Influenza A Virus, H7N9 Subtype Infections (Infectious Disease), complete with analysis by stage of development ...
Jun, 2017 73 pages... pipeline guide Hyperinsulinemia - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Hyperinsulinemia (Metabolic Disorders), complete with analysis by stage of development ...
Jun, 2017 43 pages... pipeline guide Graves Diseases - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Graves Diseases (Hormonal Disorders), complete with analysis by stage of development ...
Jun, 2017 30 pages... Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) The report reviews Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) targeted therapeutics under development ...
Jun, 2017 60 pages... therapeutic landscape for Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) The report reviews Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) targeted therapeutics under development ...
Jun, 2017 44 pages... therapeutic landscape for Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) The report reviews Iduronate 2 Sulfatase (Alpha L Iduronate Sulfate Sulfatase or Idursulfase or IDS or EC 3.1.6.13) targeted therapeutics under development ...
Jun, 2017 54 pagesDystrophin (DMD) - Pipeline Review, H1 2017 SUMMARY According to the recently published report 'Dystrophin (DMD) - Pipeline Review, H1 2017'; Dystrophin (DMD) pipeline Target constitutes close to 26 molecules. Out of which approximately 23 molecules are developed ...
Jun, 2017 70 pagesThis report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, ... etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding China ...
Jun, 2017 170 pagesThis report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, ... etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding China ...
Jul, 2017 150 pages